Newsbenzinga
Sanofi Says Nexviazyme Was Well Tolerated With Manageable Infusion-Associated Reactions In 29.4% Of Baby-COMET Participants
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…